Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 431 entries
Sorted by: Best Match Show Resources per page
The emergence of multidrug-resistant .

Lung India : official organ of Indian Chest Society

AbdulWahab A, Zahraldin K, Sid Ahmed MA, Jarir SA, Muneer M, Mohamed SF, Hamid JM, Hassan AAI, Ibrahim EB.
PMID: 29098998
Lung India. 2017 Nov-Dec;34(6):527-531. doi: 10.4103/lungindia.lungindia_39_17.

INTRODUCTION: Multidrug-resistant Pseudomonas aeruginosa (MDR-PA) is an important and growing issue in the care of patients with cystic fibrosis (CF), and a major cause of morbidity and mortality.OBJECTIVE: The objective of the study was to describe the frequency of...

Cite
AbdulWahab A, Zahraldin K, Sid Ahmed MA, et al. The emergence of multidrug-resistant . Lung India. 2017;34(6):527-531doi: 10.4103/lungindia.lungindia_39_17.
AbdulWahab, A., Zahraldin, K., Sid Ahmed, M. A., Jarir, S. A., Muneer, M., Mohamed, S. F., Hamid, J. M., Hassan, A. A. I., & Ibrahim, E. B. (2017). The emergence of multidrug-resistant . Lung India : official organ of Indian Chest Society, 34(6), 527-531. https://doi.org/10.4103/lungindia.lungindia_39_17
AbdulWahab, Atqah, et al. "The emergence of multidrug-resistant ." Lung India : official organ of Indian Chest Society vol. 34,6 (2017): 527-531. doi: https://doi.org/10.4103/lungindia.lungindia_39_17
AbdulWahab A, Zahraldin K, Sid Ahmed MA, Jarir SA, Muneer M, Mohamed SF, Hamid JM, Hassan AAI, Ibrahim EB. The emergence of multidrug-resistant . Lung India. 2017 Nov-Dec;34(6):527-531. doi: 10.4103/lungindia.lungindia_39_17. PMID: 29098998; PMCID: PMC5684810.
Copy Download .nbib Format: NLM
Low Molecular Weight Chitosan-Coated PLGA Nanoparticles for Pulmonary Delivery of Tobramycin for Cystic Fibrosis.

Pharmaceuticals (Basel, Switzerland)

Al-Nemrawi NK, Alshraiedeh NH, Zayed AL, Altaani BM.
PMID: 29517998
Pharmaceuticals (Basel). 2018 Mar 08;11(1). doi: 10.3390/ph11010028.

(1) Background: Poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) loaded with Tobramycin were prepared using a solvent-evaporation method. (2) Methods: The NPs were coated with low molecular weight chitosan (LMWC) to enhance the mucoadhesiveness of PLGA-NPs. The following

Cite
Al-Nemrawi NK, Alshraiedeh NH, Zayed AL, et al. Low Molecular Weight Chitosan-Coated PLGA Nanoparticles for Pulmonary Delivery of Tobramycin for Cystic Fibrosis. Pharmaceuticals (Basel). 2018;11(1)doi: 10.3390/ph11010028.
Al-Nemrawi, N. K., Alshraiedeh, N. H., Zayed, A. L., & Altaani, B. M. (2018). Low Molecular Weight Chitosan-Coated PLGA Nanoparticles for Pulmonary Delivery of Tobramycin for Cystic Fibrosis. Pharmaceuticals (Basel, Switzerland), 11(1), . https://doi.org/10.3390/ph11010028
Al-Nemrawi, Nusaiba K, et al. "Low Molecular Weight Chitosan-Coated PLGA Nanoparticles for Pulmonary Delivery of Tobramycin for Cystic Fibrosis." Pharmaceuticals (Basel, Switzerland) vol. 11,1 (2018). doi: https://doi.org/10.3390/ph11010028
Al-Nemrawi NK, Alshraiedeh NH, Zayed AL, Altaani BM. Low Molecular Weight Chitosan-Coated PLGA Nanoparticles for Pulmonary Delivery of Tobramycin for Cystic Fibrosis. Pharmaceuticals (Basel). 2018 Mar 08;11(1). doi: 10.3390/ph11010028. PMID: 29517998; PMCID: PMC5874724.
Copy Download .nbib Format: NLM
Evidence of inhaled tobramycin in non-cystic fibrosis bronchiectasis.

The open respiratory medicine journal

Vendrell M, Muñoz G, de Gracia J.
PMID: 25893022
Open Respir Med J. 2015 Mar 31;9:30-6. doi: 10.2174/1874306401509010030. eCollection 2015.

There is currently less experience with inhaled tobramycin in non-cystic fibrosis bronchiectasis than in cystic fibrosis (CF). Intravenous formulation and solution for inhalation (TSI) have been studied in non-CF bronchiectasis patients with chronic P. aeruginosa bronchial infection. An improvement...

Cite
Vendrell M, Muñoz G, de Gracia J. Evidence of inhaled tobramycin in non-cystic fibrosis bronchiectasis. Open Respir Med J. 2015;9:30-6doi: 10.2174/1874306401509010030.
Vendrell, M., Muñoz, G., & de Gracia, J. (2015). Evidence of inhaled tobramycin in non-cystic fibrosis bronchiectasis. The open respiratory medicine journal, 930-6. https://doi.org/10.2174/1874306401509010030
Vendrell, Montserrat, et al. "Evidence of inhaled tobramycin in non-cystic fibrosis bronchiectasis." The open respiratory medicine journal vol. 9 (2015): 30-6. doi: https://doi.org/10.2174/1874306401509010030
Vendrell M, Muñoz G, de Gracia J. Evidence of inhaled tobramycin in non-cystic fibrosis bronchiectasis. Open Respir Med J. 2015 Mar 31;9:30-6. doi: 10.2174/1874306401509010030. eCollection 2015. PMID: 25893022; PMCID: PMC4397829.
Copy Download .nbib Format: NLM
Corrigendum to "Utility of Experimental Design in Pre-Column Derivatization for the Analysis of Tobramycin by HPLC-Fluorescence Detection: Application to Ophthalmic Solution and Human Plasma".

Analytical chemistry insights

El-Zaher AA, Mahrouse MA.
PMID: 24963271
Anal Chem Insights. 2014 Jun 11;9:57. doi: 10.4137/ACI.S16710. eCollection 2014.

No abstract available.

Cite
El-Zaher AA, Mahrouse MA. Corrigendum to "Utility of Experimental Design in Pre-Column Derivatization for the Analysis of Tobramycin by HPLC-Fluorescence Detection: Application to Ophthalmic Solution and Human Plasma". Anal Chem Insights. 2014;9:57doi: 10.4137/ACI.S16710.
El-Zaher, A. A., & Mahrouse, M. A. (2014). Corrigendum to "Utility of Experimental Design in Pre-Column Derivatization for the Analysis of Tobramycin by HPLC-Fluorescence Detection: Application to Ophthalmic Solution and Human Plasma". Analytical chemistry insights, 957. https://doi.org/10.4137/ACI.S16710
El-Zaher, Asmaa A, and Mahrouse, Marianne A. "Corrigendum to "Utility of Experimental Design in Pre-Column Derivatization for the Analysis of Tobramycin by HPLC-Fluorescence Detection: Application to Ophthalmic Solution and Human Plasma"." Analytical chemistry insights vol. 9 (2014): 57. doi: https://doi.org/10.4137/ACI.S16710
El-Zaher AA, Mahrouse MA. Corrigendum to "Utility of Experimental Design in Pre-Column Derivatization for the Analysis of Tobramycin by HPLC-Fluorescence Detection: Application to Ophthalmic Solution and Human Plasma". Anal Chem Insights. 2014 Jun 11;9:57. doi: 10.4137/ACI.S16710. eCollection 2014. PMID: 24963271; PMCID: PMC4064956.
Copy Download .nbib Format: NLM
Optical Coherence Tomography Findings in Anterior Chamber Ointment Globule after Phacoemulsification.

Case reports in ophthalmology

Mansour AM, Haddad RS, Salti HI, Habbal Z.
PMID: 26955351
Case Rep Ophthalmol. 2015 Dec 19;6(3):469-76. doi: 10.1159/000442970. eCollection 2015.

We present 2 cases of anterior chamber ointment with evidence of progressive endothelial cell loss. In both cases, an anterior segment optical coherence tomography (OCT) was similar to an OCT of a tobramycin-dexamethasone ointment placed on a pen tip....

Cite
Mansour AM, Haddad RS, Salti HI, et al. Optical Coherence Tomography Findings in Anterior Chamber Ointment Globule after Phacoemulsification. Case Rep Ophthalmol. 2015;6(3):469-76doi: 10.1159/000442970.
Mansour, A. M., Haddad, R. S., Salti, H. I., & Habbal, Z. (2015). Optical Coherence Tomography Findings in Anterior Chamber Ointment Globule after Phacoemulsification. Case reports in ophthalmology, 6(3), 469-76. https://doi.org/10.1159/000442970
Mansour, Ahmad M, et al. "Optical Coherence Tomography Findings in Anterior Chamber Ointment Globule after Phacoemulsification." Case reports in ophthalmology vol. 6,3 (2015): 469-76. doi: https://doi.org/10.1159/000442970
Mansour AM, Haddad RS, Salti HI, Habbal Z. Optical Coherence Tomography Findings in Anterior Chamber Ointment Globule after Phacoemulsification. Case Rep Ophthalmol. 2015 Dec 19;6(3):469-76. doi: 10.1159/000442970. eCollection 2015. PMID: 26955351; PMCID: PMC4777953.
Copy Download .nbib Format: NLM
Antibiotic sensitivity pattern in blaNDM-1-positive and carbapenemase-producing Enterobacteriaceae.

International journal of applied & basic medical research

Mulla S, Charan J, Rajdev S.
PMID: 26958516
Int J Appl Basic Med Res. 2016 Jan-Mar;6(1):14-7. doi: 10.4103/2229-516X.173989.

BACKGROUND: Some studies published in recent time revealed that many bacteria from Enterobacteriaceae group are multi-antibiotic-resistant because of the production enzymes carbapenemase particularly New Delhi metallo-beta-lactamase encoded by gene called blaNDM-1. Looking at public health importance of this issue...

Cite
Mulla S, Charan J, Rajdev S. Antibiotic sensitivity pattern in blaNDM-1-positive and carbapenemase-producing Enterobacteriaceae. Int J Appl Basic Med Res. 2016;6(1):14-7doi: 10.4103/2229-516X.173989.
Mulla, S., Charan, J., & Rajdev, S. (2016). Antibiotic sensitivity pattern in blaNDM-1-positive and carbapenemase-producing Enterobacteriaceae. International journal of applied & basic medical research, 6(1), 14-7. https://doi.org/10.4103/2229-516X.173989
Mulla, Summaiya, et al. "Antibiotic sensitivity pattern in blaNDM-1-positive and carbapenemase-producing Enterobacteriaceae." International journal of applied & basic medical research vol. 6,1 (2016): 14-7. doi: https://doi.org/10.4103/2229-516X.173989
Mulla S, Charan J, Rajdev S. Antibiotic sensitivity pattern in blaNDM-1-positive and carbapenemase-producing Enterobacteriaceae. Int J Appl Basic Med Res. 2016 Jan-Mar;6(1):14-7. doi: 10.4103/2229-516X.173989. PMID: 26958516; PMCID: PMC4765267.
Copy Download .nbib Format: NLM
Impact of polyethylene glycol 400/propylene glycol/hydroxypropyl-guar and 0.1% sodium hyaluronate on postoperative discomfort following cataract extraction surgery: a comparative study.

Eye and vision (London, England)

Labiris G, Ntonti P, Sideroudi H, Kozobolis V.
PMID: 28497070
Eye Vis (Lond). 2017 May 10;4:13. doi: 10.1186/s40662-017-0079-5. eCollection 2017.

BACKGROUND: Universal postoperative guidelines for cataract extraction surgery are yet to be introduced. Artificial tears are gaining popularity as an additional integral component of the postoperative regime. The primary objective of this study was to explore the impact of...

Cite
Labiris G, Ntonti P, Sideroudi H, et al. Impact of polyethylene glycol 400/propylene glycol/hydroxypropyl-guar and 0.1% sodium hyaluronate on postoperative discomfort following cataract extraction surgery: a comparative study. Eye Vis (Lond). 2017;4:13doi: 10.1186/s40662-017-0079-5.
Labiris, G., Ntonti, P., Sideroudi, H., & Kozobolis, V. (2017). Impact of polyethylene glycol 400/propylene glycol/hydroxypropyl-guar and 0.1% sodium hyaluronate on postoperative discomfort following cataract extraction surgery: a comparative study. Eye and vision (London, England), 413. https://doi.org/10.1186/s40662-017-0079-5
Labiris, Georgios, et al. "Impact of polyethylene glycol 400/propylene glycol/hydroxypropyl-guar and 0.1% sodium hyaluronate on postoperative discomfort following cataract extraction surgery: a comparative study." Eye and vision (London, England) vol. 4 (2017): 13. doi: https://doi.org/10.1186/s40662-017-0079-5
Labiris G, Ntonti P, Sideroudi H, Kozobolis V. Impact of polyethylene glycol 400/propylene glycol/hydroxypropyl-guar and 0.1% sodium hyaluronate on postoperative discomfort following cataract extraction surgery: a comparative study. Eye Vis (Lond). 2017 May 10;4:13. doi: 10.1186/s40662-017-0079-5. eCollection 2017. PMID: 28497070; PMCID: PMC5424421.
Copy Download .nbib Format: NLM
Modulation of antibiotic resistance in Pseudomonas aeruginosa by ZnO nanoparticles.

Iranian journal of microbiology

Bayroodi E, Jalal R.
PMID: 27307973
Iran J Microbiol. 2016 Apr;8(2):85-92.

BACKGROUND AND OBJECTIVES: Bacterial resistance to conventional antibiotics has become a widespread public health problem. The aim of this study was to investigate the influence of zinc oxide nanoparticles (ZnO NPs) on the antibacterial activity of several conventional antibiotics...

Cite
Bayroodi E, Jalal R. Modulation of antibiotic resistance in Pseudomonas aeruginosa by ZnO nanoparticles. Iran J Microbiol. 2016;8(2):85-92
Bayroodi, E., & Jalal, R. (2016). Modulation of antibiotic resistance in Pseudomonas aeruginosa by ZnO nanoparticles. Iranian journal of microbiology, 8(2), 85-92.
Bayroodi, Elnaz, and Jalal, Razieh. "Modulation of antibiotic resistance in Pseudomonas aeruginosa by ZnO nanoparticles." Iranian journal of microbiology vol. 8,2 (2016): 85-92.
Bayroodi E, Jalal R. Modulation of antibiotic resistance in Pseudomonas aeruginosa by ZnO nanoparticles. Iran J Microbiol. 2016 Apr;8(2):85-92. PMID: 27307973; PMCID: PMC4906724.
Copy Download .nbib Format: NLM
Detecting the frequency of aminoglycoside modifying enzyme encoding genes among clinical isolates of methicillin-resistant Staphylococcus aureus.

BioImpacts : BI

Shokravi Z, Mehrad L, Ramazani A.
PMID: 26191502
Bioimpacts. 2015;5(2):87-91. doi: 10.15171/bi.2015.15. Epub 2015 Apr 21.

INTRODUCTION: Methicillin-resistant Staphylococcus aureus (MRSA) plays an important role in causing many serious nosocomial infections. In this study, the antimicrobial susceptibility and the frequency of aminoglycoside modifying enzyme encoding genes among clinical isolates of methicillin-resistant Staphylococcus aureus was investigated...

Cite
Shokravi Z, Mehrad L, Ramazani A. Detecting the frequency of aminoglycoside modifying enzyme encoding genes among clinical isolates of methicillin-resistant Staphylococcus aureus. Bioimpacts. 2015;5(2):87-91doi: 10.15171/bi.2015.15.
Shokravi, Z., Mehrad, L., & Ramazani, A. (2015). Detecting the frequency of aminoglycoside modifying enzyme encoding genes among clinical isolates of methicillin-resistant Staphylococcus aureus. BioImpacts : BI, 5(2), 87-91. https://doi.org/10.15171/bi.2015.15
Shokravi, Zahra, et al. "Detecting the frequency of aminoglycoside modifying enzyme encoding genes among clinical isolates of methicillin-resistant Staphylococcus aureus." BioImpacts : BI vol. 5,2 (2015): 87-91. doi: https://doi.org/10.15171/bi.2015.15
Shokravi Z, Mehrad L, Ramazani A. Detecting the frequency of aminoglycoside modifying enzyme encoding genes among clinical isolates of methicillin-resistant Staphylococcus aureus. Bioimpacts. 2015;5(2):87-91. doi: 10.15171/bi.2015.15. Epub 2015 Apr 21. PMID: 26191502; PMCID: PMC4492189.
Copy Download .nbib Format: NLM
A clinical comparison of two formulations of tobramycin 0.3% eyedrops in the treatment of acute bacterial conjunctivitis.

European journal of ophthalmology

Kernt K, Martinez MA, Bertin D, International Tobrex X Group Eu G, Stroman D, Cupp G, Martinez C, Tirado M, Guasch J.
PMID: 28221457
Eur J Ophthalmol. 2005 Sep - Oct 2005;15(5):541-549. doi: 10.5301/EJO.2008.993.

PURPOSE: To compare the safety and efficacy of a new enhanced viscosity ophthalmic formulation of tobramycin, given twice daily (BID), with the existing four times daily (QID) treatment regimen in patients with acute bacterial conjunctivitis.METHODS: This was a 12-day,...

Cite
Kernt K, Martinez MA, Bertin D, et al. A clinical comparison of two formulations of tobramycin 0.3% eyedrops in the treatment of acute bacterial conjunctivitis. Eur J Ophthalmol. 2005;15(5):541-549doi: 10.5301/EJO.2008.993.
Kernt, K., Martinez, M. A., Bertin, D., International Tobrex X Group Eu, G., Stroman, D., Cupp, G., Martinez, C., Tirado, M., & Guasch, J. (2005). A clinical comparison of two formulations of tobramycin 0.3% eyedrops in the treatment of acute bacterial conjunctivitis. European journal of ophthalmology, 15(5), 541-549. https://doi.org/10.5301/EJO.2008.993
Kernt, K, et al. "A clinical comparison of two formulations of tobramycin 0.3% eyedrops in the treatment of acute bacterial conjunctivitis." European journal of ophthalmology vol. 15,5 (2005): 541-549. doi: https://doi.org/10.5301/EJO.2008.993
Kernt K, Martinez MA, Bertin D, International Tobrex X Group Eu G, Stroman D, Cupp G, Martinez C, Tirado M, Guasch J. A clinical comparison of two formulations of tobramycin 0.3% eyedrops in the treatment of acute bacterial conjunctivitis. Eur J Ophthalmol. 2005 Sep - Oct 2005;15(5):541-549. doi: 10.5301/EJO.2008.993. PMID: 28221457.
Copy Download .nbib Format: NLM
Retrospective analysis of antibiotic susceptibility patterns of respiratory isolates of Pseudomonas aeruginosa in a Turkish University Hospital.

Annals of clinical microbiology and antimicrobials

Gonlugur U, Bakici MZ, Ozdemir L, Akkurt I, Icagasioglu S, Gultekin F.
PMID: 12665428
Ann Clin Microbiol Antimicrob. 2003 Mar 07;2:5. doi: 10.1186/1476-0711-2-5.

BACKGROUND: Lower respiratory tract infections due to Pseudomonas aeruginosa have a high mortality rate. Antibacterial activity of various antibiotics against P. aeruginosa isolated from each hospital depends on the variety or amount of antibiotics used in each hospital.METHOD: A...

Cite
Gonlugur U, Bakici MZ, Ozdemir L, et al. Retrospective analysis of antibiotic susceptibility patterns of respiratory isolates of Pseudomonas aeruginosa in a Turkish University Hospital. Ann Clin Microbiol Antimicrob. 2003;2:5doi: 10.1186/1476-0711-2-5.
Gonlugur, U., Bakici, M. Z., Ozdemir, L., Akkurt, I., Icagasioglu, S., & Gultekin, F. (2003). Retrospective analysis of antibiotic susceptibility patterns of respiratory isolates of Pseudomonas aeruginosa in a Turkish University Hospital. Annals of clinical microbiology and antimicrobials, 25. https://doi.org/10.1186/1476-0711-2-5
Gonlugur, Ugur, et al. "Retrospective analysis of antibiotic susceptibility patterns of respiratory isolates of Pseudomonas aeruginosa in a Turkish University Hospital." Annals of clinical microbiology and antimicrobials vol. 2 (2003): 5. doi: https://doi.org/10.1186/1476-0711-2-5
Gonlugur U, Bakici MZ, Ozdemir L, Akkurt I, Icagasioglu S, Gultekin F. Retrospective analysis of antibiotic susceptibility patterns of respiratory isolates of Pseudomonas aeruginosa in a Turkish University Hospital. Ann Clin Microbiol Antimicrob. 2003 Mar 07;2:5. doi: 10.1186/1476-0711-2-5. PMID: 12665428; PMCID: PMC152644.
Copy Download .nbib Format: NLM
Aerosolized antibiotics in cystic fibrosis.

Seminars in respiratory and critical care medicine

Sexauer WP, Fiel SB.
PMID: 16088587
Semin Respir Crit Care Med. 2003 Dec;24(6):717-26. doi: 10.1055/s-2004-815667.

Inhaled antibiotics offer an attractive alternative to systemic administration in cystic fibrosis (CF) for several reasons. Antibiotics can be administered directly to the site of infection with little systemic absorption, thereby minimizing toxicity. Aerosolization will permit chronic administration of...

Cite
Sexauer WP, Fiel SB. Aerosolized antibiotics in cystic fibrosis. Semin Respir Crit Care Med. 2003;24(6):717-26doi: 10.1055/s-2004-815667.
Sexauer, W. P., & Fiel, S. B. (2003). Aerosolized antibiotics in cystic fibrosis. Seminars in respiratory and critical care medicine, 24(6), 717-26. https://doi.org/10.1055/s-2004-815667
Sexauer, William P, and Fiel, Stanley B. "Aerosolized antibiotics in cystic fibrosis." Seminars in respiratory and critical care medicine vol. 24,6 (2003): 717-26. doi: https://doi.org/10.1055/s-2004-815667
Sexauer WP, Fiel SB. Aerosolized antibiotics in cystic fibrosis. Semin Respir Crit Care Med. 2003 Dec;24(6):717-26. doi: 10.1055/s-2004-815667. PMID: 16088587.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 431 entries